Search results
AstraZeneca Pulls Out Its COVID-19 Vaccine From Global Markets After Court Docs Shows Side Effects -...
EconoTimes· 2 days agoAstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 11 hours agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
...Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop...
FOX 4 Kansas City· 2 hours agoThe terms of the agreement include: a co-exclusive license to co-commercialize Novavax's current stand-alone adjuvanted COVID-19 vaccine
Novavax erases doubts about its ability to remain in business
KFGO· 1 hour ago(Reuters) - COVID-19 vaccine maker Novavax, on Friday, erased doubts about its ability to remain in...
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 2 days agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability
Reuters via AOL· 2 hours agoPARIS (Reuters) -Novavax on Friday erased doubts about its ability to remain in business and struck...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 2 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-& ...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 20 hours agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
France's Sanofi in COVID-19 vaccine deal with Novavax - statement
Reuters via Yahoo Finance· 2 hours agoPARIS, May 10 (Reuters) - Sanofi on Friday announced it has reached a 'co-exclusive' licensing agreement with Novavax to sell a stand-alone COVID-19 < ...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 2 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...